Treatment of MRSA in Urine

Introduction to MRSA Treatment

The American College of Physicians recommends against treating asymptomatic MRSA bacteriuria as it represents colonization rather than infection and may lead to antimicrobial resistance 1
Asymptomatic bacteriuria is defined as bacterial colonization of the urinary tract without symptoms, with bacterial growth >10^5 CFU/mL in two consecutive samples for women or in a single sample for men 1

Treatment should only be considered when MRSA in urine is accompanied by symptoms of urinary tract infection (dysuria, frequency, urgency, suprapubic pain) 1
Treating asymptomatic MRSA bacteriuria can lead to selection of antimicrobial resistance and eradication of potentially protective bacterial strains 1

Treatment is indicated for symptomatic MRSA urinary tract infections, according to the Infectious Diseases Society of America 2, 1
Treatment should be considered before urological procedures breaching the mucosa, as recommended by the American Urological Association 1
Treatment is recommended for pregnant women with MRSA bacteriuria, as stated by the American College of Obstetricians and Gynecologists 1

IV vancomycin is the mainstay of parenteral therapy for MRSA infections, including UTIs, as recommended by the Infectious Diseases Society of America 2
Linezolid 600 mg PO/IV twice daily is an effective alternative to vancomycin for treating MRSA UTIs, according to the Clinical Infectious Diseases journal 2

For uncomplicated MRSA UTIs, 7-14 days of therapy is typically recommended, as stated by the Infectious Diseases Society of America 2
For complicated infections or those with bacteremia, longer courses of therapy may be necessary, according to the Clinical Infectious Diseases journal 2
Rifampin should not be used as monotherapy due to rapid emergence of resistance but may be considered as part of combination therapy, as recommended by the Infectious Diseases Society of America 2

IV vancomycin is recommended for children with MRSA infections, according to the American Academy of Pediatrics 2, 3
If the patient is stable without ongoing bacteremia, clindamycin can be used as empirical therapy if local resistance rates are low (<10%), with transition to oral therapy if the strain is susceptible, as stated by the American Academy of Pediatrics 3
Linezolid dosing for children: 600 mg PO/IV twice daily for children >12 years of age and 10 mg/kg/dose every 8 hours for children <12 years of age, as recommended by the American Academy of Pediatrics 3
Tetracyclines should not be used in children <8 years of age, according to the American Academy of Pediatrics 2

Treating asymptomatic MRSA bacteriuria unnecessarily contributes to antimicrobial resistance, as stated by the American College of Physicians 1
Failure to remove infected intravascular or prosthetic devices is associated with higher relapse and mortality rates, according to the Infectious Diseases Society of America 4
Using rifampin as monotherapy rapidly leads to resistance, as recommended by the Infectious Diseases Society of America 2
Inadequate duration of therapy for complicated infections can lead to treatment failure, according to the Clinical Infectious Diseases journal 2

The American College of Physicians recommends Trimethoprim-sulfamethoxazole (TMP-SMX) as the preferred first-line oral agent for MRSA UTI, with a dosage of 1-2 double-strength tablets orally twice daily 5
The Infectious Diseases Society of America suggests alternative oral options, including Clindamycin, 300-450 mg orally three times daily, Doxycycline, 100 mg orally twice daily, and Minocycline, 200 mg loading dose, then 100 mg orally twice daily, if TMP-SMX is contraindicated 5

The Centers for Disease Control and Prevention recommends reevaluating patients in 24-48 hours if treated as outpatients to verify clinical response, and obtaining follow-up urine cultures 48-72 hours after initiating therapy to document clearance of infection 6